Person

Sally E. Blount

Director, Abbott Laboratories

Current S&P 500 boards
1
Current roles
1
Open-market buys
$248K
Open-market sales
$669K

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Apr 30, 2025ABTSale2,600$129.66$337K
Jun 26, 2020ULTABuy250$193.00$48K
Jul 31, 2019ABTSale2,500$87.65$219K
Jun 21, 2019ULTASale315$359.28$113K
Nov 1, 2016ABTBuy5,100$39.24$200K

SEC reporting-owner ID (CIK) 1537286 · all filings on EDGAR

Sally E. Blount (ABT) | USBoard